Arcutis Biotherapeutics, Inc.ARQTNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-6.66%
↑ 74% above average
Average (7y)
-25.44%
Historical baseline
Range
High:-1.78%
Low:-110.56%
CAGR
-12.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -6.66% | +94.0% |
| 2023 | -110.56% | -220.4% |
| 2022 | -34.50% | -101.3% |
| 2021 | -17.14% | -51.7% |
| 2020 | -11.30% | -117.5% |
| 2019 | -5.19% | -191.3% |
| 2018 | -1.78% | +89.1% |
| 2017 | -16.40% | - |